Trial intelligence / Profile preview

Armour Thyroid vs Levothyroxine Dose Conversion Study

NCT04124705Phase 2Completed

Sponsor
Allergan
Start
Oct 2019
Primary completion
Jun 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of thyroid, porcine in hypothyroidism, sponsored by Allergan. Started Oct 2019; status: completed.

02

Drugs

thyroid, porcine
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT04124705.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04124705.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call